RAGONA, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 4.547
EU - Europa 3.224
AS - Asia 1.763
AF - Africa 67
SA - Sud America 47
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.657
Nazione #
US - Stati Uniti d'America 4.452
CN - Cina 1.004
IT - Italia 521
IE - Irlanda 421
DE - Germania 419
SG - Singapore 352
UA - Ucraina 331
FR - Francia 316
SE - Svezia 308
FI - Finlandia 268
GB - Regno Unito 210
KR - Corea 197
AT - Austria 148
CA - Canada 90
PL - Polonia 85
VN - Vietnam 67
DK - Danimarca 55
IN - India 50
SN - Senegal 44
BR - Brasile 29
BE - Belgio 25
JP - Giappone 22
NL - Olanda 22
UZ - Uzbekistan 18
ES - Italia 17
CZ - Repubblica Ceca 16
CH - Svizzera 12
HK - Hong Kong 12
ID - Indonesia 12
RU - Federazione Russa 12
MU - Mauritius 9
AR - Argentina 8
PT - Portogallo 7
RO - Romania 7
TH - Thailandia 7
AU - Australia 6
BY - Bielorussia 6
GR - Grecia 6
TR - Turchia 6
HR - Croazia 5
IR - Iran 5
MA - Marocco 5
TN - Tunisia 5
TW - Taiwan 5
CO - Colombia 3
EC - Ecuador 3
EU - Europa 3
NO - Norvegia 3
VE - Venezuela 3
ZA - Sudafrica 3
IL - Israele 2
MX - Messico 2
PK - Pakistan 2
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
CL - Cile 1
DZ - Algeria 1
IS - Islanda 1
JM - Giamaica 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 9.657
Città #
Beijing 754
Chandler 589
Santa Clara 461
Dublin 417
Singapore 275
Houston 227
Ann Arbor 224
Jacksonville 205
Ashburn 182
Villeurbanne 172
Medford 150
Princeton 149
Vienna 143
Torino 129
Nyköping 123
Wilmington 121
Columbus 113
Fairfield 101
Fremont 92
Dearborn 76
Milan 76
Warsaw 66
Woodbridge 59
Verona 51
Dong Ket 46
Toronto 45
Pisa 44
Boston 43
Redwood City 39
Falls Church 33
Boardman 32
Cambridge 31
Seattle 31
Munich 28
Lachine 26
Hefei 22
Mountain View 22
Guangzhou 21
Norwalk 21
Brussels 19
Washington 17
Helsinki 16
Shanghai 16
Nanjing 15
Rome 15
Brno 14
San Mateo 13
Jakarta 12
New York 12
Padova 11
Düsseldorf 10
Kunming 10
Los Angeles 10
Zhengzhou 10
Hangzhou 8
Pune 8
Turin 8
Nürnberg 7
Redmond 7
San Diego 7
Auburn Hills 6
Lublin 6
Marseille 6
San Jose 6
Seoul 6
Chengdu 5
Chongqing 5
Des Moines 5
Esfahan 5
Hong Kong 5
Jinan 5
Madrid 5
Nanchang 5
Ningbo 5
Ottawa 5
San Maurizio Canavese 5
Tokyo 5
Tunis 5
Wuhan 5
Atlanta 4
Berlin 4
Central District 4
Chicago 4
Florence 4
Guangdong 4
Hebei 4
London 4
Miami 4
Paris 4
Phoenix 4
Saint Cloud 4
Scarmagno 4
São Paulo 4
Taiyuan 4
Taranto 4
Zagreb 4
Zaragoza 4
Amsterdam 3
Barcelona 3
Buenos Aires 3
Totale 5.865
Nome #
Distinct Effects of Leukocyte and Cardiac Phosphoinositide 3-Kinase {gamma} Activity in Pressure Overload-Induced Cardiac Failure 298
Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy 292
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series 241
Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospecitve trial 221
Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy 189
[Absorbed doses in dental radiology] 175
Incorporating18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation 154
Adjuvant radiotherapy influences the survival of patients with squamous carcinoma of the head and neck who have poor prognoses. 153
Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy 141
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 132
Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients 129
[Evaluation of various phonatory parameters in laryngectomized patients: comparison of esophageal and tracheo-esophageal prosthesis phonation] 127
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 118
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 113
Carcinoma of the larynx in the elderly: analysis of potentially significant prognostic variables. 110
Absolute and relative dose measurements with Gafchromic EBT film for high energy electron beams with different doses per pulse. 109
Angiogenesis: prognostic significance in laryngeal cancer. 108
Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes 108
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 107
Exclusive Radiotherapy for Early-stage Glottic Cancer: A Single-institution Retrospective Analysis with a Focus on Voice Quality 106
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study 102
Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer 99
[Prognostic factors in the radio-surgical treatment of laryngeal carcinoma] 98
Hypofractionation with no boost after breast conservation in early-stage breast cancer patients 95
Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation. 95
[The reliability of echotomographic diagnosis in assessing thyroid lesions. A comparison with cytology and histology] 94
null 94
[Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck] 93
[Image deformation in dental radiography: 3 different technics compared] 93
Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation 93
Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm 89
B-cell chronic lymphocytic leukaemia stage 0. An immunophenotypic study of 66 cases and comparison with B small cell lymphomas. 88
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 87
[Complications of tracheostomy in critically ill patients: comparison of dilation and surgical techniques]. 85
Microvessel count is predictive of patients' survival in laryngeal squamous-cell carcinoma. 84
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx 83
125I brachytherapy for localized prostate cancer: a single institution experience 83
Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients 83
Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective 83
Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e 83
Three-Dimensional Ultrasound-Based Image-Guided Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Results of a Consecutive Case Series. 82
Lateral high abdominal ovariopexy: an original surgical technique for protection of the ovaries during curative radiotherapy for Hodgkin's disease. 81
Clinical use of EBT model Gafchromic film in radiotherapy 81
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment. 81
Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer. 81
[Multi-center study of recurrent nasal sinus polyposis: prognostic factors and possibility of prophylaxis] 80
Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? 77
Results of chemotherapy plus external reirradiation in the treatment of locally advanced recurrences of nasopharyngeal carcinoma. 76
[Carcinoma of the base of the tongue: a case series] 76
Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer. Definitive results of a phase I-II study. 75
[Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases] 74
Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations. 74
[Total skin therapy with electron beams. II. Clinical results in mycosis fungoides] 74
[Laryngeal cancer and angiogenesis] 73
Research project in dosimetry,treatment planning,patient alignment and radiometabolic treatments 73
Impact of the observers' experience on daily prostate localization accuracy in ultrasound-based IGRT with the Clarity platform 72
ARE STILL FIDUCIAL MARKERS ALONE APPROPRIATE IN THE IMAGE GUIDED ERA FOR PROSTATE CANCER RADIOTHERAPY? A SINGLE INSTITUTION EXPERIENCE BASED ON A “WELL TRAINED” PATIENT SUBGROUP 71
Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients 71
[Total skin therapy with electron beams. I. Physical and geometric factors] 70
[5- and 10-year survival in carcinomas of the oral cavity (T1-2/N0-1) treated with external radiotherapy alone or associated with surgery and/or chemotherapy] 70
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 70
[Characterization of a diode system for in vivo dosimetry with electron beams] 69
Chemo-radiotherapy in lung cancer: state of the art with focus on the elderly population 69
Prognostic factors of cervical lymph node metastasis in head and neck squamous cell carcinoma. 67
[A method for rapid and precise positioning of screens in the treatment using irregularly shaped fields] 67
Treatment Planning of proton beams using GEANT Monte Carlo 67
CT–MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. 66
Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy. 65
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 65
Effects of continuing or stopping exposure to risk-factors on natural history of laryngeal precancerous lesions 62
Guidelines for quality assurance in total body irradiation 62
Evaluation of a commercial automatic treatment planning system for liver stereotactic body radiation therapy treatments 62
Stereotactic body radiation therapy for early non-small cell lung cancer: experience at the University of Turin 61
Surgery or radiotherapy for early stages carcinomas of the glottic larynx. 61
Radiotherapy after surgery for advanced adenoid cystic carcinoma of paranasal sinus 61
Comparison of three-dimensional Monte Carlo simulation and the pencil beam algorithm for an electron beam from a linear accelerator 60
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk. 60
[Comparison of dosimetric protocols for beams of photons and electrons] 59
null 59
Efficacy and safety of Tadalafil 20 mg on demand vs. Tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial. 58
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 58
[Prognostic factors in the treatment of carcinoma of the cervix uteri in IB-IIA stage. Retrospective study] 57
Technique, dosimetry and results of total body irradiation in preparation to ABMT in Torino. 55
Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy. 55
High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma. 55
Prostate brachytherapy with iodine-125 seeds: radiation protection issues 55
Scleromyxedema: treatment of widespread cutaneous involvement by total skin electron-beam therapy 55
Prostate-specific antigen kinetics after I125-brachytherapy for prostate adenocarcinoma 54
Interstitial hyperthermia (IHT): technical problems and methodology. 53
[Prognostic factors in the treatment of advanced cervical cancer. A retrospective study] 53
Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999. 53
Topical role of brachytherapy: economic and organizational aspects. 52
[High-dose-rate brachytherapy. The indications, technic and preliminary results] 51
Three new applicators for hyperthermia. 51
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial 51
[Technic and dosimetry in total body irradiation with 18 MeV photons] 50
Stereotactic body radiation therapy for lung metastases. 50
Treatment of malignant neoplasms of the parotid gland. 50
[Radiologic hyperthermia with microwaves and radio-frequencies. I. Presentation of a multifrequency system] 49
[Results of radiotherapy in the treatment of 218 carcinomas of the tonsillar area] 49
Totale 8.773
Categoria #
all - tutte 31.781
article - articoli 0
book - libri 0
conference - conferenze 680
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020594 0 0 0 0 0 0 145 70 117 127 94 41
2020/2021892 75 60 90 65 60 43 98 43 123 82 50 103
2021/2022978 22 56 30 36 30 39 88 54 34 61 220 308
2022/20231.777 194 154 27 171 154 470 139 118 213 32 70 35
2023/2024662 88 135 42 37 44 68 16 31 8 26 35 132
2024/20251.170 17 72 43 206 676 133 23 0 0 0 0 0
Totale 10.048